General Nurse Practitioner News

NP

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Haberl R - In the clinical setting high dose magnesium abolished torsade-de-pointes tachycardias caused by antiarrhythmic drugs. Unfortunately, controlled studies are not available for low dose electrolyte therapy adjuvant to antiarrhythmic drug medication.

Related Articles

Beta-adrenergic Modulation of Arrhythmogenesis and Identification of Targeted Sites of Antiarrhythmic Therapy in Timothy (LQT8) Syndrome: A Theoretical Study
Heart And Circulatory Physiology, 11/06/09    Relevance Score: 65%

Omega-3 fatty acids and heart failure
Current Atherosclerosis Reports, 11/12/09    Relevance Score: 64%

Atrial fibrillation: from ion channels to bedside treatment options
Journal of Electrocardiology, 11/05/09    Relevance Score: 64%

Women with atrial fibrillation: Greater risk, less attention
Gender Medicine, 10/21/09    Relevance Score: 63%

Issues in postmenopausal hormone therapy: depression, endometrial health, and discontinuation
Sexuality, Reproduction & Menopause, 10/09/09    Relevance Score: 47%

Today in Clinical Pharmacology...keeping you current

The Statin Choice decision aid in primary care: A randomized trial
Patient Education and Counselling, 12/04/09

Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk
Cleveland Clinic Journal of Medicine, 12/04/09

Q: Is an ACE inhibitor plus an ARB more effective than either drug alone?
Cleveland Clinic Journal of Medicine, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address